Crosstalk between Platelet and Bacteria: A Therapeutic Prospect

Area of Science:

• Immunology
• Hematology
• Microbiology

Background:

• Platelets are crucial for hemostasis and vascular repair.
• Beyond hemostasis, platelets are implicated in atherosclerosis, stroke, thrombosis, and infections.
• During infection, platelets engage with bacteria via direct and indirect mechanisms.

Purpose of the Study:

• To review the interaction mechanisms between platelets and bacteria.
• To explore how these interactions contribute to thrombotic disorders.
• To identify potential therapeutic targets for infection-induced cardiovascular complications.

Main Methods:

• Review of scientific literature on platelet-bacteria interactions.
• Analysis of cellular and molecular mechanisms involved.
• Identification of key platelet receptors and host molecules.

Main Results:

• Platelet surface receptors (e.g., GPIbα, FcγRIIA, GPIIbIIIa, TLRs) mediate direct bacterial interaction.
• Host plasma proteins (e.g., vWF, fibronectin, IgG, fibrinogen) facilitate indirect interactions.
• Bacterial-induced platelet activation leads to aggregation, thrombus formation, and Neutrophil Extracellular Traps (NETs) release, promoting thrombosis.

Conclusions:

• Platelets act as immune modulators during infection, potentially leading to cardiovascular complications.
• Understanding platelet-bacteria interactions is key to developing therapies against infection-induced thrombotic disorders.
• Targeting specific platelet receptors and enzymes could mitigate infection-induced platelet activation and associated pathologies.